|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| | Secteur
| Var. 1janv
 /  | Capitalisation (M$)
 / | Note Investissement
/ | CT
| MT
| LT
|
 |
| 1 - | UCB | Pharmacie - diversifié | 18.89% | 8 463 | |  | | |
| 2 - | TUBIZE-FIN | Pharmacie - diversifié | 26.64% | 1 730 | - | | | |
| 3 - | THROMBOGENICS | Biotechnologie | 19.15% | 919 | |  | | |
| 4 - | GALAPAGOS | Biotechnologie | 12.03% | 393 | |  | | |
| 5 - | ABLYNX (D) | Biotechnologie | -21.11% | 149 | | | | |
| 6 - | TIGENIX (D) | Biotechnologie | -36.99% | 52 | | | | |
| 7 - | MDXHEALTH | Biotechnologie | 5.59% | 35 | - | | | |
|
|
